Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate the overall response rate and safety data of RO5072759 (1000mg flat dose) given as monotherapy in patients with relapsed CD20+ indolent NHL compared with rituximab(375mg/m2) monotherapy.
Critère d'inclusion
- Patients with CD20+ Non-Hodgkins Lymphoma and Leukemia